Gtcr Investment Xi LLC
CIK: 0001827977
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 13, 2026SHC
Sotera Health Co
Sale(S)Indirect12.7M shares at avg. $15.17$193.2M - Mar 6, 2026SHC
Sotera Health Co
Sale(S)Indirect10M shares at avg. $15.27$152.7M - Dec 3, 2025SHC
Sotera Health Co
Sale(S)Indirect6.5M shares at avg. $16.33$105.8M - Nov 10, 2025SHC
Sotera Health Co
Sale(S)Indirect12M shares at avg. $15.65$187.8M - Sep 5, 2025SHC
Sotera Health Co
Sale(S)Indirect8M shares at avg. $15.11$120.9M - Sep 6, 2024SHC
Sotera Health Co
Sale(S)Indirect10M shares at avg. $15.03$150.3M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 13, 2026 | SHC Sotera Health Co | Sale(S) | 12,735,301 | $15.17 | $193,169,046 | Indirect |
| Mar 6, 2026 | SHC Sotera Health Co | Sale(S) | 10,000,000 | $15.27 | $152,700,000 | Indirect |
| Dec 3, 2025 | SHC Sotera Health Co | Sale(S) | 6,480,000 | $16.33 | $105,818,400 | Indirect |
| Nov 10, 2025 | SHC Sotera Health Co | Sale(S) | 12,000,000 | $15.65 | $187,812,000 | Indirect |
| Sep 5, 2025 | SHC Sotera Health Co | Sale(S) | 8,000,000 | $15.11 | $120,888,000 | Indirect |
| Sep 6, 2024 | SHC Sotera Health Co | Sale(S) | 10,000,000 | $15.03 | $150,300,000 | Indirect |
1-6 of 6 transactions
About GTCR INVESTMENT XI LLC
GTCR INVESTMENT XI LLC (SEC CIK 0001827977) files insider reports with the SEC as Director of Sotera Health Co (SHC) and 10% Owner of Vivid Seats Inc. (SEAT).
Signal8 holds 7 ownership filings by GTCR INVESTMENT XI LLC (1 Form 3, 6 Form 4), filed between Sep 9, 2024 and May 15, 2026. Those filings report 6 transactions, from Sep 6, 2024 to May 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GTCR INVESTMENT XI LLC's filings is in CHICAGO, IL.
Recent filings by GTCR INVESTMENT XI LLC
- May 13, 2026: Open-market sale of SHC shares (Form 4, code S).
- Mar 6, 2026: Open-market sale of SHC shares (Form 4, code S).
- Dec 3, 2025: Open-market sale of SHC shares (Form 4, code S).
- Nov 10, 2025: Open-market sale of SHC shares (Form 4, code S).
- Sep 5, 2025: Open-market sale of SHC shares (Form 4, code S).
Other insiders filing for Sotera Health Co (SHC)
- Petras Michael B. Jr., Executive Chairman
- Rutz Michael P, President of Sterigenics
- Lyons Jonathan M., Sr. Vice President, CFO
- Klee Ann R., Director
- SHADER ALTON, Chief Executive Officer
- Kyle Richard G, Director